Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms
Zhu, Liangliang1,2; Ge, Guangbo1; Zhang, Hongbo3; Liu, Huixin1; He, Guiyuan1,2; Liang, Sicheng1; Zhang, Yanyan1; Fang, Zhongze1; Dong, Peipei1; Finel, Moshe3
刊名drug metabolism and disposition
2012-03-01
卷号40期号:3页码:529-538
通讯作者杨凌
产权排序1,1
英文摘要magnolol is a food additive that is often found in mints and gums. human exposure to this compound can reach a high dose; thus, characterization of magnolol disposition in humans is very important. previous studies indicated that magnolol can undergo extensive glucuronidation in humans in vivo. in this study, in vitro assays were used to characterize the glucuronidation pathway in human liver and intestine. assays with recombinant human udp-glucuronosyltransferase enzymes (ugts) revealed that multiple ugt isoforms were involved in magnolol glucuronidation, including ugt1a1, -1a3, -1a7, -1a8, -1a9, -1a10, and -2b7. magnolol glucuronidation by human liver microsomes (hlm), human intestine microsomes (him), and most recombinant ugts exhibited strong substrate inhibition kinetics. the degree of substrate inhibition was relatively low in the case of ugt1a10, whereas the reaction catalyzed by ugt1a9 followed biphasic kinetics. chemical inhibition studies and the relative activity factor (raf) approach were used to identify the individual ugts that played important roles in magnolol glucuronidation in hlm and him. the results indicate that ugt2b7 is mainly responsible for the reaction in hlm, whereas ugt2b7 and ugt1a10 are significant contributors in him. in summary, the current study clarifies the glucuronidation pathway of magnolol and demonstrates that the raf approach can be used as an efficient method for deciphering the roles of individual ugts in a given glucuronidation pathway in the native tissue that is catalyzed by multiple isoforms with variable and atypical kinetics.
学科主题物理化学
WOS标题词science & technology ; life sciences & biomedicine
类目[WOS]pharmacology & pharmacy
研究领域[WOS]pharmacology & pharmacy
关键词[WOS]human liver-microsomes ; drug-glucuronidation ; substrate ; expression ; cytochrome-p450 ; specificity ; selectivity ; metabolism ; dopamine ; kinetics
收录类别SCI
语种英语
WOS记录号WOS:000300610100017
公开日期2013-10-11
内容类型期刊论文
源URL[http://159.226.238.44/handle/321008/118375]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Lab Pharmaceut Resource Discovery, Dalian Inst Chem Phys, Dalian 116023, Peoples R China
2.Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
3.Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland
推荐引用方式
GB/T 7714
Zhu, Liangliang,Ge, Guangbo,Zhang, Hongbo,et al. Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms[J]. drug metabolism and disposition,2012,40(3):529-538.
APA Zhu, Liangliang.,Ge, Guangbo.,Zhang, Hongbo.,Liu, Huixin.,He, Guiyuan.,...&Yang, Ling.(2012).Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms.drug metabolism and disposition,40(3),529-538.
MLA Zhu, Liangliang,et al."Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms".drug metabolism and disposition 40.3(2012):529-538.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace